Cargando…
A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential
The psychedelic alkaloid ibogaine has anti-addictive properties in both humans and animals.(1) Unlike most substance use disorder (SUD) medications, anecdotal reports suggest that ibogaine possesses the potential to treat patients addicted to a variety of substances including opiates, alcohol, and p...
Autores principales: | Cameron, Lindsay P., Tombari, Robert J., Lu, Ju, Pell, Alexander J., Hurley, Zefan Q., Ehinger, Yann, Vargas, Maxemiliano V., McCarroll, Matthew N., Taylor, Jack C., Myers-Turnbull, Douglas, Liu, Taohui, Yaghoobi, Bianca, Laskowski, Lauren J., Anderson, Emilie I., Zhang, Guoliang, Viswanathan, Jayashri, Brown, Brandon M., Tjia, Michelle, Dunlap, Lee E., Rabow, Zachary T., Fiehn, Oliver, Wulff, Heike, McCorvy, John D., Lein, Pamela J., Kokel, David, Ron, Dorit, Peters, Jamie, Zuo, Yi, Olson, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874389/ https://www.ncbi.nlm.nih.gov/pubmed/33299186 http://dx.doi.org/10.1038/s41586-020-3008-z |
Ejemplares similares
-
Psychedelic medicine and the clinical application of hallucinogens
por: eClinicalMedicine
Publicado: (2023) -
Developmental
Neurotoxicity Screen of Psychedelics
and Other Drugs of Abuse in Larval Zebrafish (Danio rerio)
por: Tombari, Robert J., et al.
Publicado: (2023) -
Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
por: dos Santos, Rafael G., et al.
Publicado: (2020) -
Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions
por: Girala, N.
Publicado: (2022) -
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2021)